摘要
为探讨妇女白细胞介素-6(IL-6)及雌激素水平的变化对骨丢失的影响,本文采用四甲基偶氮唑盐微量酶反应比色法(MTT)检测青年妇女、围绝经妇女及绝经后妇女的血清IL-6活性,用放免法检测血清雌二醇(E2)水平,双能X线吸收仪测定L2~4的骨密度(BMD)。结果表明:绝经后妇女的血清IL-6活性明显升高,但血清E2水平却显著低于青年妇女与围绝经妇女(P<0.01),BMD也显著低于青年妇女与围绝经妇女(P<0.01)。相关分析显示,IL-6与BMD呈负相关(r=-0.724,P<0.05),与E2呈负相关(r=-0.759,P<0.01),E2与BMD呈正相关(r=0.660,P<0.01)。提示,E2缺乏及其所致的IL-6水平升高在绝经后骨质疏松的发病机制中起重要作用。
In order to explore the effects of serum interleukin-6 (IL-6) and serum estrogen level on women bone loss, we examined the serum IL-6 activity with MTT assay,serum E2 level with radioimmunoassay and bone mineral density (BMD) at L2-4 using dual-energy X-ray absorptiometer (DEXA) in young women,periclimateric women and postmenopausal women.The results showed that the IL-6 activity was significantly higher in postmenopausal women,whereas the serum E2 level was significantly lower in postmenopausal women compared with young women and periclimateric women(P<0.01);the BMD was also significantly lower in postmenopausal women(P<0.01).Moreever,the IL-6 had negative correlation with BMD (r=-0.724,P<0.05),and negative correlation with E2(r=-0.759,P<0.01);while E2 had positive correlation with BMD(r=0.660,P<0.01).These results suggest that the decrease of E2 and the increased production of IL-6 may play an important role in the pathogenesis of postmenopausal osteoporosis.
出处
《标记免疫分析与临床》
CAS
1999年第2期65-67,共3页
Labeled Immunoassays and Clinical Medicine
关键词
骨质疏松
绝经后
白细胞介素-6
雌激素
Osteoporosis,postmenopausalInterleukin-6EstrogenBone mineral density